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Abstract
Stimulus-induced gamma oscillations in the 30–80 Hz range have been implicated in a wide number of functions including
visual processing, memory and attention. While occipital gamma-band oscillations can be pharmacologically modified in
animal preparations, pharmacological modulation of stimulus-induced visual gamma oscillations has yet to be
demonstrated in non-invasive human recordings. Here, in fifteen healthy humans volunteers, we probed the effects of
the GABAA agonist and sedative propofol on stimulus-related gamma activity recorded with magnetoencephalography,
using a simple visual grating stimulus designed to elicit gamma oscillations in the primary visual cortex. During propofol
sedation as compared to the normal awake state, a significant 60% increase in stimulus-induced gamma amplitude was
seen together with a 94% enhancement of stimulus-induced alpha suppression and a simultaneous reduction in the
amplitude of the pattern-onset evoked response. These data demonstrate, that propofol-induced sedation is accompanied
by increased stimulus-induced gamma activity providing a potential window into mechanisms of gamma-oscillation
generation in humans.
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Introduction
Gamma oscillations in the 30–80 Hz range have been
implicated in a wide number of functions including, memory
[1], attention [2] and consciousness [3], and are thought to be
disturbed in schizophrenia [4]. Both neurophysiological data
and modelling studies provide convergent evidence that the
most plausible mechanism for the generation of temporally-
organised gamma activity is in reciprocally connected neuronal
networks containing an interconnected mixture of pyramidal
cells, stellate cells and GABAergic inhibitory interneurons [5,6].
Consistent with this, gamma oscillations recorded from primary
visual cortex slices in vitro have been shown to be modulated by
drugs that target GABAA receptors as well as drugs that target
glutamatergic AMPA and NMDA receptors [7], and acetylcho-
line receptors [8]. However, the neurochemical basis and
pharmacological modifiability of the spatially-summated, popu-
lation-level, gamma-band responses that can be recorded from
primary visual cortex non-invasively in humans with magne-
toencephalography (MEG) and electroencephalography (EEG)
are largely unknown.
In this experiment we attempted to modulate stimulus-
induced gamma oscillations using the GABAA agonist propofol.
Most of the information about propofol’s in vivo modulation of
neurophysiologic gamma oscillatory activity is based on in-
vestigating spontaneous EEG activity after loss of consciousness.
Loss of spatiotemporal organisation of gamma oscillations and
information integration capacity has been shown at anaesthetic
doses of propofol [9]. However, Murphy et al [10] showed
a persistently increased gamma activity with increased connec-
tivity between the regions of the default-mode network (DMN)
during propofol anaesthesia challenging the role of gamma
oscillations in predicting consciousness. The relationship be-
tween spontaneous gamma activity, stimulus-induced activity
and potential muscle artefacts in the spontaneous EEG is
unclear [11,12].
We investigated the modifiability of stimulus-induced gamma
activity, in fifteen healthy humans during an intermediate state of
consciousness, that is, sedation without loss of consciousness. MEG
was used to measure oscillatory responses to a simple grating
stimulus during propofol sedation and during normal wakefulness.
Importantly, the stimulation paradigm and data processing
techniques that we used have previously been shown to be highly
reproducible, stable to repetition effects, and hence suitable for
crossover neuropharmacology studies [13]. Further, MEG is
robust to the muscle artefact contamination that has affected
EEG studies of gamma oscillations [11,14]. Our results demon-
strate that, compared to the normal awake state, propofol-induced
sedation is accompanied by an increase in visual stimulus-induced
gamma-band activity as well as increased alpha desynchronisation
and decreased visual evoked responses.
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Materials and Methods
Volunteers
Fifteen right-handed, healthy, male volunteers (mean age 26
years; range 20–41 years) were recruited following a detailed
screening procedure. The study was approved by Cardiff
University’s Research Ethics Committee and all volunteers gave
informed written consent. Medical screening was performed to
ensure that all participants were in good physical and mental
health and not on any regular medication (American Society of
Anesthesiologists physical status 1). Any volunteer with complaints
of regular heartburn or hiatus hernia, known or suspected allergies
to propofol (or its constituents), regular smokers, those who snored
frequently or excessively, or who had a potentially difficult-to-
manage airway were excluded.
Monitoring, Drug Administration and Sedation
Assessment
Throughout the experiments, all participants were monitored in
accordance with guidelines from the Association of Anaesthetists
of Great Britain by two anaesthetists. Heart rate (HR), non-
invasive blood pressure (BP), oxygen saturation (SpO2) and
concentrations of expired carbon-dioxide (EtCO2) were continu-
ously monitored using Veris H MR Vital Signs monitoring system
(Medrad) and recorded every 5 minutes. The monitoring system
was located outside the magnetically shielded room. The
connecting cables passed through waveguides into the magneti-
cally shield room. This monitoring setup was tested and found to
add no noise to the MEG signals. The monitoring anaesthetists
observed the participants through a video monitor and maintained
verbal contact, as required, through an intercom system.
Volunteers were instructed to follow standard pre-anaesthetic
fasting guidelines. They avoided food for six hours and any
fluids for two hours before the experiments. Of the two
anaesthetists supervising the sessions, one was solely responsible
for participant monitoring and was not actively involved in the
experiment. Intravenous access (20 gauge) was obtained on the
dorsum of the right hand and physiological monitoring (HR,
BP, SpO2 and EtCO2) was instituted. Nasal cannulae were used
for sampling of expired and inspired gases and the administra-
tion of oxygen, as required. Propofol (Propofol-Lipuro 1%,
Braun Ltd., Germany) was administered using an Asena H- PK
infusion pump (Alaris Medical, UK) using a target controlled
infusion based on the Marsh-pharmacokinetic model [15].
While participants lay supine in the magnetically shielded
room, infusion was started targeting an effect-site concentration
of 0.6 mcg/ml. Once the target was reached, two minutes were
allowed to ensure reliable equilibration. Drug infusion was then
increased in 0.2 mcg/ml increments until the desired level of
sedation was achieved. Sedation level was assessed by an
anaesthetist, blinded to the level of propofol being administered,
using the modified Observer’s assessment of alertness/sedation
scale (OAA/S) [16]. Sedation endpoint was an OAA/S level of
4 (slurred speech with lethargic response to verbal commands).
The same anaesthetist (NS) assessed this endpoint on every
occasion to ensure consistency of the depth of sedation
achieved. Reaction times in response to auditory and visual
stimuli were also recorded during the awake and sedated states
both before and after completion of the stimulation paradigm.
As expected, reaction times were significantly lower during
sedation compared to waking but not significantly different
before and after the stimulation session, further indicating that
a steady state had been achieved.
Stimulation Paradigm
Once steady state sedation was achieved, participants were
presented with a visual stimulus consisting of a vertical, stationary,
maximum contrast, three cycles per degree, square-wave grating
presented on a mean luminance background. The stimulus was
presented in the lower left visual field and subtended 4u both
horizontally and vertically. A small red fixation square was located
at the top right hand edge of the stimulus, which remained on for
the entire stimulation protocol [17,18]. The stimulus was
presented on a projection screen controlled by PresentationH.
The duration of each stimulus was 1.5–2 s followed by 2 s of
fixation only. Participants were instructed to fixate for the entire
experiment and in order to maintain attention were instructed to
press a response key at the termination of each stimulation period.
Responses slower than 750 ms triggered a brief visual warning for
participants. 100 stimuli were presented in a recording session and
participants responded with their right hand. Each recording
session took approximately 10 min and was carried out before
sedation and then repeated during sedation. The awake recording
was always carried out before the sedation session on the same
day. We have previously demonstrated the robustness of this
paradigm to temporal order effects [13].
MEG Acquisition and Analysis
Whole head MEG recordings were made using a CTF 275-
channel radial gradiometer system sampled at 1200 Hz (0–300 Hz
bandpass). An additional 29 reference channels were recorded for
noise cancellation purposes and the primary sensors were analysed
as synthetic third-order gradiometers [19]. Three of the 275
channels were turned off due to excessive sensor noise. At the
onset of each stimulus presentation a TTL pulse was sent to the
MEG system. Participants were fitted with three electromagnetic
head coils (nasion and pre-auriculars), which were localised
relative to the MEG system immediately before and after the
recording session. Each participant had a 1 mm isotropic T1
weighted MRI scan available for source localisation analysis. To
achieve MRI/MEG co-registration, the fiduciary markers were
placed at fixed distances from anatomical landmarks identifiable in
participants’ anatomical MRIs (tragus, eye centre). Fiduciary
locations were verified afterwards using digital photographs.
Offline, data were first epoched from 21.5 to 1.5 s around
stimulus onset and each trial visually inspected for data quality.
Data with gross artifacts, such as head movements and muscle
contractions were excluded from further analysis. Two source
localisations were performed on each dataset using synthetic
aperture magnetometry, one for induced responses (SAM), and
one for evoked responses (SAMerf). Correspondingly, two global
covariance matrices were calculated for each dataset, one for SAM
(40–80 Hz) and one for SAMerf (0–100 Hz). Based on these
covariance matrices, using the beamformer algorithm [20], two
sets of beamformer weights were computed for the entire brain at
4 mm isotropic voxel resolution. A multiple local-spheres [21]
volume conductor model was derived by fitting spheres to the
brain surface extracted by FSL’s Brain Extraction Tool [22].
For gamma-band SAM imaging, virtual sensors were con-
structed for each beamformer voxel and student t images of source
power changes computed using a baseline period of 21.5 to 0 s
and an active period of 0 to 1.5 s. Within these images, the voxel
with the strongest power increase (in the contralateral occipital
lobe) was located. To reveal the time–frequency response at this
peak location, the virtual sensor was repeatedly band-pass filtered
between 1 and 150 Hz at 0.5 Hz frequency step intervals using an
8 Hz bandpass, 3rd order Butterworth filter [13,23]. The Hilbert
transform was used to obtain the amplitude envelope and spectra
Propofol and Visual Gamma
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were computed as a percentage change from the mean pre-
stimulus amplitude (21.5 to 0 s) for each frequency band. This
relative-change baseline provides a control for between-recording
and between-participant effects (for example, different head
positions in the MEG), as well as correcting for the 1/f nature
of non-baseline corrected MEG source estimates [24]. From these
spectra, the time courses of alpha (8–15 Hz) and gamma (40–
80 Hz) were extracted and submitted to non-parametric permu-
tation tests using 5000 permutations [25,26]. Permuted t statistics
were corrected for multiple comparisons using cluster-based
techniques with an initial cluster forming threshold of t=2.3.
This approach allowed us to examine the temporal profile of
oscillatory spectral modulations as well as controlling for potential
contamination of early-evoked response components into the
alpha band. To examine pre-stimulus amplitudes the time-
frequency spectra were recomputed with no baseline correction
and the average amplitudes of alpha (8–15 Hz), beta (15–40 Hz)
and gamma (40–80 Hz) in the pre-stimulus period (21.5 to 0 s)
were calculated.
For SAMerf, the computed evoked response was passed through
the 0–100 Hz beamformer weights and SAMerf images [27] were
generated at 0.01 s intervals from 0.05 to 0.015 s. The image
(usually 0.08 to 0.09 s or 0.09 to 0.1 s) with the maximal response
in visual cortex was identified and the maximal voxel selected as
Figure 1. Summary of total (evoked plus induced) amplitude differences in the experiment. a) Grand-averaged source localisation of
gamma oscillations (40–80 Hz) for awake and sedated states respectively. Units are t statistics. The peak source location for the gamma band was at
MNI co-ordinate [15–95 7] for awake and [17 97 1] for sedated (adjacent SAM voxels). b) Grand-averaged time-frequency spectrograms showing
source-level oscillatory amplitude (evoked+induced) changes following visual stimulation with a grating patch (stimulus onset at time= 0) during
awaked and sedated states. Spectrograms are displayed as percentage change from the pre-stimulus baseline and were computed for frequencies
from 5 up to 150 Hz but truncated here to 100 Hz for visualisation purposes. c) Envelopes of oscillatory amplitude for the gamma (40–80 Hz) and
alpha (8–15 Hz) bands respectively. Time-periods with significant differences between the awake and sedated states are indicated with a black bar
(*p,.05, **p,.01, ***p,.001, shaded areas represent SEM).
doi:10.1371/journal.pone.0057685.g001
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the peak location for virtual sensor analysis. For time-domain
analysis, the evoked field was computed for this virtual sensor
(20.2 to 0 s baseline, 40 Hz low-pass filter) and the peak
amplitude and latency of the M100 and M150 responses were
quantified. We also performed a spectral analysis of the evoked
field using the same time-frequency techniques as above. The
evoked frequency response in the 0 to 0.2 s period was obtained
for each condition and analysed using the same statistical
methodology.
Results
Participants showed significantly (t=6.15, p= .001) slower key
presses to stimulus offset during propofol sedation (mean 355 (s.d.
42) ms) compared to the awake state (mean 277 (33) ms). They also
missed significantly more (t=3.86, p= .002) key presses during
sedation (6.1 (4.7)) compared to the awake state (1.3 (1.0)).
Figure 1A shows grand-averaged source reconstructions for
gamma band (40–80 Hz) responses to presentation of the grating
stimulus during awake and sedated states respectively. As
expected, both reconstructions locate the sources in the medial
visual cortex in the quadrant opposite to the side of visual
stimulation. The grand-averaged peak locations of the responses
were located in adjacent source reconstruction voxels (4 mm voxel
size). From the peak locations identified in individual source
localisation images, source level activity was reconstructed and
time-frequency spectra computed. The grand-average of these
time-frequency spectra are displayed in Figure 1B. These show the
typical morphology following this type of visual stimulus: there is
an initial transient broadband (50 to 100 ms) amplitude increase in
the gamma frequency (.40 Hz) range, followed by a longer-
lasting elevation of gamma frequency amplitude in a narrower
frequency range [13,28]. In the lower frequencies, there exists
a sustained alpha amplitude decrease that commences around
200 ms, and a low frequency onset response, which is indicative of
the evoked response [29]. Co-localisation of alpha and gamma
responses has been previously demonstrated [30]. In Figure 1C the
extracted gamma (40–80 Hz) and alpha (8–15 Hz) amplitude
time-courses are plotted. During propofol sedation there was
significantly elevated (p= .01, corrected) gamma band activity
between 0.15 to 0.61 s corresponding to a 59.8% increase in
amplitude. Similarly, during propofol sedation there was signifi-
cantly (p,.01, corrected) more alpha amplitude decrease between
0.230 to 1.25 s corresponding to a 94.0% increase in stimulus-
induced alpha suppression.
In Figure 2A, the time-frequency response of the source-level
evoked response is presented for both awake and sedated states
and in Figure 2B the frequency spectra of these are presented for
Figure 2. Summary of evoked amplitude differences in the experiment. a) Grand-averaged time-frequency spectrograms showing source-
level oscillatory amplitude changes for the evoked response. b) Evoked amplitude spectra for the 0–0.2 s time period. c) Source-level time-averaged
evoked responses for awake and sedated states. Significant differences were seen in the amplitude of the M100 and M150 responses (*p,.05,
**p,.01, ***p,.001, shaded areas represent SEM).
doi:10.1371/journal.pone.0057685.g002
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0 to 0.2 s time window (i.e. where Figure 2A indicates that bulk of
evoked activity occurred). Figure 2B indicates significantly less
evoked power in the sedated state. Figure 2C presents the time-
averaged evoked responses and demonstrates significant reduc-
tions in both the amplitude of the M100 (46%) and M150 (94%)
components during propofol sedation. We also noted significant
(t=3.16, p= .007) slowing of the M100 component (Figure 3B).
The M150 component was reduced to such a level during propofol
sedation that we were unable to adequately quantify latency for
a number of participants. Figure 3A demonstrates that there was
no shift in peak gamma frequency, while peak alpha frequencies
could not be reliably estimated across participants. We then tested
whether the changes in alpha and gamma activity could be driven
by changes in the baseline power spectrum. To do this, we
computed the absolute amplitudes of the virtual sensor amplitude
spectra in the baseline period. No changes were seen in baseline
gamma or alpha amplitude but an increase in resting beta
amplitude (p= .05) (Figure 3C–E) was seen.
We conducted exploratory correlational analyses between each
of the parameters we had found to be significantly modulated by
propofol (differences in, reaction time, gamma amplitude, alpha
amplitude, M100 latency, M150 latency, and beta baseline
amplitude). The only correlation that emerged was between
M100 latency differences and alpha amplitude differences (r= .57,
p,.003) and will require subsequent confirmation.
Discussion
In this experiment, we demonstrate that during mild propofol
sedation there is an increase in visually-induced gamma band
responses, increased alpha amplitude suppression, and a concur-
rent reduction in the visually evoked response compared to the
awake state. Thus, there is an overall amplification of the
oscillatory response seen with visual stimulation under propofol
sedation but a decrease in evoked activity. This provides an in vivo
demonstration in humans, that stimulus-induced gamma oscilla-
tions in visual cortex can be modified pharmacologically. The
increase in induced gamma and alpha stimulus reactivity occurred
concurrently with a reduction in the evoked response, that is, the
evoked and induced responses showed a pharmacologically-in-
duced dissociation. One particularly striking feature of this
dissociation is that this occurred in the same MEG data. This
suggests that these two MEG responses may reflect the activity of
different generator populations in primary visual cortex or that
these generators are differentially pharmacologically sensitive.
Indeed, in primary visual cortex gamma band responses are
primarily generated in layers II, III and IV [31], whereas early
evoked responses are mostly generated in layer IV [32]. The
present dissociation appears comparable to the dissociation
between ERP and the gamma responses recorded during an
adaptation (double pulse paradigm) task, using subdural record-
ings. While there was a reduction in the ERP the gamma-band
response remained constant [33]. An important aspect of this
dissociation is that it argues against other, more prosaic,
interpretations of the data. For example, one might argue that
the reduction in the M100 amplitude evoked response is due to
reduced task vigilance, attention [34] as participants’ state of
consciousness changed. However, these effects would also decrease
the amplitude of oscillatory responses [18,34]. The concurrent
increase in oscillatory signals is therefore inconsistent with such
arguments. Another possibility is that the decreased evoked
responses we observed might be due to altered fixation control
during propofol sedation. However, loss of fixation control would
be expected to decrease the amplitude of both the evoked response
[35] and the gamma-band response [36,18] whereas these
components change in opposite directions in our data. Neverthe-
Figure 3. Bar charts showing peak gamma frequency (a), M100 Latency (b), and baseline gamma (c), beta (d) and alpha amplitudes
(e). (*p,.05, **p,.01, ***p,.001, bars represent SEM).
doi:10.1371/journal.pone.0057685.g003
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less, measurement of fixation position via either eye-tracking or
electrooculography would be a useful addition to future experi-
ments.
EEG studies of the resting spectra during mild propofol sedation
demonstrate decreased posterior alpha and increased central beta
power [37]. Increased sedation levels are marked by increased
delta and theta power and frontal alpha with increased peak
frequency [38]. Neural modelling of the changes in the resting
EEG spectra during propofol anaesthesia suggests that these are
caused by increased inhibition within local interneuron circuits
[39,40]. While the scalp EEG is a mixture of many generators, the
advantage of the MEG beamformer approach used here is that it
allows activity from a spatially confined region of interest to be
analysed [19]. The baseline spectra in our primary visual cortex
virtual sensors demonstrated only a relatively minor increase in
beta power and no changes in resting gamma or alpha activity. As
such, the event-related amplitude changes we demonstrate here do
not appear to be related to baseline spectral changes with the drug.
The other advantage of the well-validated MEG beamfomer
[13,28,30] approach used here is that we can be very confident
that the gamma-band activity here does not reflect the influence of
muscle activity, be it from microsaccades [14,41], or neck/head
muscles [11].
In a recent observational study in humans we found that, across
individuals, the frequency of stimulus-induced network gamma
oscillations in primary visual cortex is positively correlated with the
concentration of GABA measured with edited magnetic resonance
spectroscopy [42]. A similar correlation between GABA concen-
tration and gamma frequency has been observed in the motor
cortex [43]. Based on these results, it might be expected that
gamma frequency would increase with propofol but instead we
found that gamma amplitude increased. Because, magnetic
resonance spectroscopy is an indirect measure of synaptic GABA
function our previous correlational results could be influenced by
a number of anatomical, biochemical or even genetic variables. In
particular, recently Schwarzkopf et al. [44] found across individ-
uals, that gamma frequency correlates with the surface area of V1
defined by retinotopic mapping with fMRI, suggesting anatomical
factors may have driven our previous results. While we observed
here a change in gamma amplitude and not frequency, and
gamma amplitude and frequency are not correlated across
individuals [13], across experimental manipulations they often
change together and perhaps they should not be viewed as isolated
parameters. For example, in both animals [45] and humans [18],
it has been shown that moving stimuli lead to gamma oscillations
of both higher frequency and amplitude. Similarly, when the
contrast of stimuli changes, induced gamma oscillations (dynam-
ically) change in both amplitude [46] and frequency [47]. In
addition, stimuli of different spatial frequency elicit not only
different gamma amplitudes [48] but also alter the spectral shape
of the gamma response [49]. Finally, recent computational
modelling studies suggest that individual variability in both spatial
integration across V1 columns [50] and synaptic excitation/
inhibition [50,51] can drive variability in induced visual gamma
frequency, suggesting a possible dependence on multiple param-
eters.
While propofol exerts a small amount of activity on nAch,
AMPA and NMDA receptors as well as sodium chanels its
principal mechanism of action is thought to be via potentiation of
GABAA receptors [52]. In vitro, the primary action of propofol at
low concentrations is to potentiate GABA evoked hyperpolarising
Cl- currents [53,54] and at higher concentrations directly activate
Cl- currents via the b-subunit in human recombinant GABA-A
receptors [55]. At clinically relevant concentrations propofol
causes a concentration dependent increase in the duration of
synaptic miniature IPSCs [56], an increase in extrasynaptic tonic
inhibitory currents [57] and, in hippocampal neurons, increases
both the amplitude and decay time length of IPSCs [58].
Computational modelling [59] suggests that gamma activity can
be generated by networks of gap junction connected interneurons
[60] providing large synchronised IPSPs to excitatory cells [61].
Indeed, in barrel cortex, driving fast-spiking interneuron activity,
but not pyramidal cell activity, selectively amplifies gamma activity
[62]. Given all of these previous results, the amplified gamma
response we observe here seems most likely to be caused by the
potentiation of GABAA activity by propofol. Gamma amplitude
changes could result from the enhancement of either phasic or
tonic GABA currents, as propofol amplifies both [63,64,65] and
both can modify gamma activity [62,66]. The fact that both
gamma amplitude and alpha suppression were enhanced suggests
an overall increase in excitatory oscillatory effects with propofol.
The significant effects seen here with propofol certainly warrant
future investigations using more targeted GABAergic agents.
Finally, we note another very recent study using the cholinergic
agonist phystostigmine which found a selective modulation of
alpha oscillation amplitude in response to visual stimuli in humans
with MEG [67]. This study, which included a more attentionally
demanding task than ours, also found pharmacologically altered
gamma-band activity in the right frontal cortex (but not in visual
cortex). Taken together, these studies demonstrate the potential of
MEG to non-invasively characterise the selective effects of
pharmacological agents on quantitative neuronal biomarkers.
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